Molecular cytogenetics in translational oncology: When chromosomes meet genomics

Clinical and Translational Oncology

Volumn 10, Issue 1, 2008, Pages 20-29

  Calasanz, M José ^a   Cigudosa, Juan C ^b,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c Centro Nacional de Investigations Oncológicas   (Spain)

Author keywords

Array CGH; Chromosome rearrangements; FISH; Fusion genes; Translocations

Indexed keywords

ABELSON KINASE; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; BREAKPOINT CLUSTER REGION PROTEIN; COMPLEMENTARY DNA; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; GEFITINIB; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INTERFERON REGULATORY FACTOR 4; MIXED LINEAGE LEUKEMIA PROTEIN; NUCLEOPORIN 98; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN BCL 2; PROTEIN BCL 3; PROTEIN KINASE LCK; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR TAL1; TRASTUZUMAB; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; BREAST CANCER; CANCER GENETICS; CARCINOMA; CHROMOSOME ADDITION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA CONTENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FUSION; GENOMICS; HUMAN; KARYOTYPING; MICROARRAY ANALYSIS; NONHODGKIN LYMPHOMA; REVIEW; SARCOMA; SINGLE NUCLEOTIDE POLYMORPHISM; SOLID TUMOR; ANIMAL; CHROMOSOME ABERRATION; DNA MICROARRAY; GENE TRANSLOCATION; GENETICS; NEOPLASM; NUCLEIC ACID HYBRIDIZATION;

ANIMALS; CHROMOSOME ABERRATIONS; GENE AMPLIFICATION; GENOMICS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSLOCATION, GENETIC;

EID: 43249100359     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-008-0149-1     Document Type: Review

References (46)

1. Mitelman F, Johansson B, Mertens F (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7:233-245
2. Tjio JH, Levan A (1956) The chromosome number of men. Hereditas 42:1-6
3. Nowell PC, Hungerford DA (1960) A minute chromosome in human chronic granulocytic leukemia. Science 132:1497
4. Mitelman F, Johansson B, Mertens F (2007) Mitelman Database of Chromosome Aberrations in Cancer [online]. http://cgap.nci.nih.gov/ Chromosomes/Mitelman
5. Kearney L, Horsley SW (2005) Molecular cytogenetics in haematological malignancy: Current technology and future prospects. Chromosoma 114:286-294
6. Speicher MR, Carter NO (2005) The new cytogenetics: Blurring the boundaries with molecular biology. Nat Rev Genet 6:782-792
7. Futreal PA, Coin L, Marshall M et al (2004) A census of human cancer genes. Nat Rev Cancer 4:177-183
8. Sjöblom T, Jones S, Wood LD et al (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274
9. Rowley JD (2001) Chromosome translocations: Dangerous liaisons revisited. Nat Rev Cancer 1: 245-250
10. Tomlins SA, Laxman B, Dhanasekaran SM et al (2007) Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448:595-599
11. Tomlins SA, Rhodes DR, Perner S et al (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-648
12. Mitelman F, Johansson B, Mertens F (2004) Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 36:331-334
13. Vanden Bempt I, Drijkoningen M, De Wolf-Peeters C (2007) The complexity of genotypic alterations underlying HER2-positive breast cancer: An explanation for its clinical heterogeneity. Curr Opin Oncol 19:552-557
14. Johnson PH, Esteva FJ (2007) The use of HER2 modulation in the adjuvant setting. Curr Oncol Rep 9:9-16
15. Wolff AC, Hammond ME, Schwartz JN et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118-145
16. Engelman JA, Cantley LC (2006) The role of the ErbB family members in non-small cell lung cancers sensitive to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 12:4372s-4376s
17. Swanton C, Futreal A, Eisen T (2006) Targeted therapies in non-small cell lung cancer. Clin Cancer Res 12:4377s-4383s
18. Martinez-Ramirez A, Urioste M, Contra T et al (2001) Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia. Haematologica 86:1245-1253
19. Martinez-Ramirez A, Cigudosa JC, Maestre L et al (2004) Simultaneous detection of the immunophenotypic markers and genetic aberrations on routinely processed paraffin sections of lymphoma samples by means of the FICTION technique. Leukemia 18:348-353
20. Saez B, Martin-Subero JI, Odero MD et al (2007) Multicolor interphase cytogenetics for the study of plasma cell dyscrasias. Oncol Rep 18:1099-1106
21. Sherbenou DW, Druker BJ (2007) Applying the discovery of the Philadelphia chromosome. J Clin Invest 117:2067-2074
22. Veldman T, Vignon C, Schrock E et al (1997) Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15:406-410
23. Cigudosa JC, Calasanz MJ, Garcia Miranda JL (1999) Multicolor spectral karyotyping (SKY) and its application to the cytogenetic diagnosis of multiple myeloma. Sangre (Barc) 44:301-304
24. Cigudosa JC, Odero MD, Calasanz MJ et al (2003) De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19. Genes Chromosomes Cancer 36:406-412
25. Martinez-Ramirez A, Rodriguez Perales S, Melendez B et al (2003) Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet Cytogenet 141: 138-142
26. Rao PH, Cigudosa JC, Ning Y et al (1998) Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood 92:1743-1748
27. Rodriguez-Perales S, Martinez-Ramirez A, de Andres SA et al (2004) Molecular cytogenetic characterization of rhabdomyosarcoma cell lines. Cancer Genet Cytogenet 148:35-43
28. Saez B, Martin-Subero JI, Largo C et al (2006) Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses. Cancer Genet Cytogenet 169:143-149
29. Kallioniemi A, Kallioniemi OP, Sudar D et al (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821
30. Gebhart E, Verdorfer I, Saul W et al (2000) Delimiting the use of comparative genomic hybridization in human myeloid neoplastic disorders. Int J Oncol 16:1099-1105
31. Gebhart, E (2005) Genomic imbalances in human leukemia and lymphoma detected by comparative genomic hybridization (Review). Int J Oncol 27: 593-606
32. Lucito R, West J, Reiner A et al (2000) Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res 10:1726-1736
33. Mei R, Galipeau PC, Prass C et al (2000) Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res 10:1126-1137
34. Pollack JR, Perou CM, Alizadeh AA et al (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23:41-46
35. Solinas-Toldo S, Lampel S, Stilgenbauer S et al (1997) Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20:399-407
36. Fiegler H, Carr P, Douglas EJ et al (2003) DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36: 361-374
37. Ishkanian AS, Malloff CA, Watson SK et al (2004) A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36:299-303
38. Paulsson K, Heidenblad M, Strömbeck B et al (2006) High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia 20:840-846
39. Rücker FG, Bullinger L, Schwaenen C et al (2006) Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 24:3887-3894
40. Rücker FG, Sander S, Döhner K et al (2006) Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations. Leukemia 20:994-1001
41. Martinez-Ramirez A, Urioste M, Melchor L et al (2005) Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 42:287-298
42. Alvarez S, Cigudosa JC (2005) Gains, losses and complex karyotypes in myeloid disorders: A light at the end of the tunnel. Hematol Oncol 23:18-25
43. Suela J, Largo C, Ferreira B et al (2007) Neurofibromatosis 1, and Not TP53, seems to be the main target of chromosome 17 deletions in de novo acute myeloid leukemia. J Clin Oncol 25:1151-1152
44. Suela J, Alvarez S, Cifuentes F et al (2007) DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups. Leukemia 21:1224-1231
45. Gorletta TA, Gasparini P, D'Elios MM et al (2005) Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype. Genes Chromosomes Cancer 44:334-337
46. Raghavan M, Lillington DM, Skoulakis S et al (2005) Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 65:375-378